🔎 Trials Near Me

Beranda › Anemia › Georgia

Uji klinis Anemia di Georgia

7 studi untuk Anemia mencari peserta di lokasi di Georgia.

Kota di Georgia

Teks studi resmi (Bahasa Inggris)

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  • Emory University, Atlanta
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07623161

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

  • Emory Winship Cancer Institute, Atlanta
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05320198

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  • Emory University, Atlanta
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07422480

Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients

  • Childrens Healthcare of Atlanta, Atlanta
Menerima pesertaFase 3
Usia 2 hingga 18 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06934967

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  • Arthur M. Blank Hospital- Children's Healthcare of Atlanta, Atlanta
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07224360

A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

  • Gwinnett Research Institute, Buford
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 17 Apr 2026 · NCT03893045

Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease

  • Grady Health System, Atlanta
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 ke atas · Wanita · Diperbarui 18 Feb 2026 · NCT06979492

Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.